Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Uroacitides plus interventional therapy and chemotherapy for advanced cholangiocarcinoma
ChiCTR-TRC-08000066Phase 4Recruiting
- Sponsor
- The First Affiliated Hospital of Zhengzhou University
- Start
- Jan 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of uroacitides in cholangiocarcinoma (CCA) (2 arms), sponsored by The First Affiliated Hospital of Zhengzhou University. Primary endpoints: Survival rate and Tumor improvement. Started Jan 2008; status: recruiting.
02
Drugs
uroacitides
03
Conditions
cholangiocarcinoma (CCA)
Beyond the preview
Go deeper on ChiCTR-TRC-08000066.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-08000066.